Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04199624 · ClinicalTrials.gov registry record · Phase 1
Assessment of Gastric pH Changes Induced by Ascorbic Acid Tablets
A Phase 1 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 1
- Development phase
- 11
- Enrollment target
NCT04199624 is a Phase 1 study that has completed, run by Indiana University. The registered enrollment target is 11 participants.
The verdict
NCT04199624, a Phase 1 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 11 participants
- Enrollment target
Study Summary
This study evaluates the use of ascorbic acid, vitamin C, to temporary reduce gastric pH in individuals with omeprazole induced hypochlorhydria. All participants will receive ascorbic acid tablets to measure the change in gastric pH.
Interventions
- DIETARY_SUPPLEMENT Vitamin C
- DRUG Omeprazole 20mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2021-10-01 |
| Est. Completion | 2023-06-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04199624
The ClinicalTrials.gov registry entry for NCT04199624 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vitamin C is the first listed.
NCT04199624 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04199624 about?
NCT04199624 is a clinical study titled "Assessment of Gastric pH Changes Induced by Ascorbic Acid Tablets". This study evaluates the use of ascorbic acid, vitamin C, to temporary reduce gastric pH in individuals with omeprazole induced hypochlorhydria. All participants will receive ascorbic acid tablets to measure the change in gastric pH.
What is the current status of trial NCT04199624?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 11 participants. The study started on 2021-10-01. Estimated completion is 2023-06-07.
What interventions are being tested in trial NCT04199624?
The interventions under investigation include: Vitamin C (DIETARY_SUPPLEMENT), Omeprazole 20mg (DRUG).
Who is sponsoring clinical trial NCT04199624?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.